Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 769 - 776 of 11617 results
New York Governor Vetoes Non-Compete Ban
December 23, 2023| Blog| Viewpoint
Energy & Sustainability Washington Update —January 2024
December 22, 2023| Blog| Viewpoint
5th Circuit Strictly Interprets Sackett Directive Over WOTUS Definition
December 22, 2023| News
Court Vacates SEC’s New Share Repurchase Disclosure Rules
December 21, 2023| Advisory| Viewpoint
Doing Well to Do Good
December 21, 2023| Article| Viewpoint
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting
December 21, 2023| Blog| Viewpoint
New Partner Helps Mintz Offer RE Services In Canada
December 21, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.